Infectious enteritis after intestinal transplantation: Incidence, timing, and outcome

被引:22
作者
Ziring, D [1 ]
Tran, R [1 ]
Edelstein, S [1 ]
McDiarmid, SV [1 ]
Vargas, J [1 ]
Cortina, G [1 ]
Gajjar, N [1 ]
Ching, N [1 ]
Cherry, J [1 ]
Krogstad, P [1 ]
Renz, JF [1 ]
Fondevila, C [1 ]
Busuttil, RW [1 ]
Farmer, DG [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dumont UCLA Transplant Program, Div Liver & Pancreas Transplantat, Los Angeles, CA 90024 USA
关键词
D O I
10.1016/j.transproceed.2004.01.093
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aim. To review the incidence, timing, and outcome of infectious enteritis after intestinal transplantation (IT). Method. A retrospective review of all patients undergoing IT at a single institution between 1991 and 2003 was analyze with standard statistical tools. Results. Among 33 IT recipients, 13 (39%) developed 20 culture- or biopsy-proven episodes of infectious enteritis. The recipient demographics were 77% men and median age 2.6 years. Infections were diagnosed at a median of 76 days (32 to 1800) after IT. There were 14 viral (CMV one, rotavirus eight, adenovirus four, EBV one, three bacterial (Clostridium difficile), and three other infections (Giardia lamblia one, cryptosporidium two). Complete resolution was achieved in 17 (94%) infectious after appropriate antimicrobial or conservative therapy. Interestingly, there were six rejection episodes following infectious enteritis. Grafts were lost to rejection after rotaviral enteritis (n = 1) and adenoviral enteritis misdiagnosed as rejection (n = 1). Patient and graft survival were not adversely affected by infections. Conclusions. Infectious enteritis occurs frequently after IT. Viral agents are the cause in two-thirds of cases. With supportive care and appropriate treatment, resolution is possible in the majority of cases. Differentiating rejection and infection by histopathology can be difficult.
引用
收藏
页码:379 / 380
页数:2
相关论文
共 5 条
[1]   Diagnosis and treatment of cryptosporidium infection in intestinal transplant recipients [J].
Delis, SG ;
Tector, J ;
Kato, T ;
Mittal, N ;
Weppler, D ;
Levi, D ;
Ruiz, P ;
Nishida, S ;
Nery, JR ;
Tzakis, AG .
TRANSPLANTATION PROCEEDINGS, 2002, 34 (03) :951-952
[2]   Effectiveness of aggressive prophylatic and preemptive therapies targeted against cytomegaloviral and Epstein-Barr viral disease after human intestinal transplantation [J].
Farmer, DG ;
McDiarmid, SV ;
Winston, D ;
Yersiz, H ;
Cortina, G ;
Dry, S ;
Maxfield, AJ ;
Vandenbogaart, B ;
Correa, M ;
Kroeber, A ;
Geevarghese, S ;
Busuttil, RW .
TRANSPLANTATION PROCEEDINGS, 2002, 34 (03) :948-949
[3]   Adenovirus infection in pediatric liver and intestinal transplant recipients: Utility of DNA detection by PCR [J].
McLaughlin, GE ;
Delis, S ;
Kashimawo, L ;
Cantwell, GP ;
Mittal, N ;
Cirocco, RE ;
Ruiz, P ;
Kato, T ;
Tzakis, AG .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (02) :224-228
[4]   Pediatric intestinal transplantation: The resected allograft [J].
Noguchi, S ;
Reyes, J ;
Mazariegos, GV ;
Parizhskaya, M ;
Jaffe, R .
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2002, 5 (01) :3-21
[5]   Adenovirus infection in pediatric small bowel transplantation recipients [J].
Pinchoff, RJ ;
Kaufman, SS ;
Magid, MS ;
Erdman, DD ;
Gondolesi, GE ;
Mendelson, MH ;
Tane, K ;
Jenkins, SG ;
Fishbein, TM ;
Herold, BC .
TRANSPLANTATION, 2003, 76 (01) :183-189